Rare Lung Disease II

HomePatientsLung Disease Week at the ATS2014Rare Lung Disease II ▶ Information for Experts
Information for Experts

Rare Lung Disease

Clinician
ATS Educational Products

2014

Hot Topics in Pediatric Lung Rare Diseases
BREATHMAKING PROGRESS IN RARE INTERSTITIAL LUNG DISEASES

Clinician
ATS Journal articles on Hermansky-Pudlak Syndrome

Circulating Fibrocytes as Biomarker of Prognosis in Hermansky-Pudlak Syndrome
Read Abstract

Dysregulation of Galectin-3. Implications for Hermansky-Pudlak Syndrome Pulmonary Fibrosis
Vol. 50, No. 3 (2014), pp. 605-613
Read Abstract

Elevated Chitinase-3-Like-1 And Impaired Trafficking Of IL-13Rα2 Contribute To Pulmonary Injury And Fibroproliferative Repair In Hermansky-Pudlak Syndrome
Read Abstract

Enhancing ER-Chaperone Function Attenuates Bleomycin-Induced Lung Fibrosis In SFTPC But Not Hermansky-Pudlak Syndrome Mutant Mice
Volume 181 (1 Meeting Abstracts); May, 2010 – A1471
Read Abstract

Altered Migration Capacity Of Lung Fibroblasts From Patients With Hermansky-Pudlak Syndrome
Read Abstract

Clinician
ATS Statements, Guidelines and Reports

ATS Statements, Guidelines and Reports are printed in the American Journal of Respiratory and Critical Care Medicine. These documents are also available in PDF format. You may download one copy of any ATS document; there is no charge for this service. Some examples below: